Brand Name:

Diajard Forte XR

Generic Name:

Empagliflozin+Linagliptin+Metformin HCI

Composition:

DIAJARD FORTE XR 5MG/2.5MG/1000MG TABLET:

EACH FILM-COATED EXTENDED-RELEASE TABLET CONTAINS:
EMPAGLIFLOZIN 5MG. LINAGLIPTIN 2,5MG. (AS IMMEDIATE RELEASE COATING)
METFORMIN HCI (AS EXTENDED-RELEASE CORE) 1000MG

DIAJARD FORTE XR 10MG/5MG/1000MG TABLET
EACH FILM-COATED EXTENDED-RELEASE TABLET CONTAINS:
EMPAGLIFLOZIN 10MG. LINAGLIPTIN 5MG. (AS IMMEDIATE RELEASE COATING)
METFORMIN HCI (AS EXTENDED-RELEASE CORE) 1000MG
DIAJARD FORTE XR 12.5MG/2.5MG/1000MG TABLET
EACH FILM-COATED EXTENDED-RELEASE TABLET CONTAINS:
EMPAGLIFLOZIN 12.5MG. LINAGLIPTIN 2.5MG. (AS IMMEDIATE RELEASE COATING) METFORMIN HCI (AS EXTENDED-RELEASE CORE) 1000MG
DIAJARD FORTE XR 25MG/5MG/1000MG TABLET:
EACH FILM-COATED EXTENDED-RELEASE TABLET CONTAINS:
EMPAGLIFLOZIN 25MG. LINAGLIPTIN 5MG.(AS IMMEDIATE RELEASE COATING) METFORMIN HCI (AS EXTENDED-RELEASE CORE) 1000MG

DESCRIPTION:

DIAJARD FORTE XR
(EMPAGLIFLOZIN+LINAGLIPTIN+METFORMIN HCI)
IS A PRESCRIPTION MEDICINE USED TO TREAT: DIABETES MELLITUS TYPE-2

INDICATIONS:

Diabetes type-2 patients on prescription of a doctor

PRESENTATION:

DIAJARD FORTE XR 5MG/2.5MG/1000MG TABLET
DIAJARD FORTE XR 10MG/5MG/1000MG TABLET
DIAJARD FORTE XR 12.5MG/2.5MG/1000MG TABLET
DIAJARD FORTE XR 25MG/5MG/1000MG TABLET